Key result
Preoperative risk scores show modest discrimination with ~0.70 AUC for post-LVAD right ventricular failure.
Why the study?
Multiple preoperative risk scores and hemodynamic parameters have been proposed to predict RVF after LVAD implantation, but their generalizability remains uncertain.
Do published preoperative risk scores and hemodynamic parameters accurately predict right ventricular failure in patients undergoing centrifugal-flow LVAD implantation?
Observational (n=331)
No
Do published preoperative risk scores and hemodynamic parameters accurately predict right ventricular failure in patients undergoing centrifugal-flow LVAD implantation?
Published preoperative risk scores demonstrate only modest discrimination (AUC ~0.70) and poor calibration for predicting right ventricular failure after centrifugal-flow LVAD implantation, highlighting the need for center-specific risk awareness and perioperative management.
Answers are grounded in this paper and cite their sources.
Existing scores should not yet guide centrifugal LVAD candidate selection; leaves open need for refined RV failure prediction models.
Right ventricular failure (RVF) remains a major complication after left ventricular assist device (LVAD) implantation and is associated with increased morbidity and mortality. Multiple preoperative risk scores and hemodynamic parameters have been proposed to predict RVF; however, their generalizability remains uncertain. We performed a retrospective single-center study of 331 patients undergoing centrifugal-flow LVAD implantation between 2011 and 2025, excluding axial-flow devices. Right ventricular failure, defined by Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) criteria, occurred in 105 patients (31.7%). We evaluated established hemodynamic parameters and published risk scores using logistic regression, standalone receiver operating characteristic analysis, calibration assessment, and sensitivity analyses. Although several risk scores, including European Registry for Patients with Mechanical Circulatory Support (EUROMACS), Utah, and STOP-RVF, were associated with RVF, their discriminative performance was modest, with area under the curve values around 0.70. Discrimination remained modest in the HeartMate 3 subgroup and when postoperative right-sided mechanical circulatory support requirement was used as a more objective endpoint. Calibration analyses showed that published risk strata did not consistently reproduce original absolute event rates, and the incremental improvement beyond preoperative models for predicting a dynamic, institution-dependent complication. Center-specific risk awareness and proactive perioperative management strategies may better mitigate RVF risk.
No takes yet. Share an insight, caveat, or question.
Sakata et al. (2026) conducted an observational in Right ventricular failure after left ventricular assist device implantation (n=331). Preoperative risk scores (EUROMACS, Utah, STOP-RVF) and hemodynamic parameters was evaluated on Right ventricular failure (INTERMACS criteria) (AUC ~0.70). Preoperative risk scores (EUROMACS, Utah, STOP-RVF) showed modest discrimination for right ventricular failure, which occurred in 31.7% of centrifugal-flow LVAD recipients.
Synapse has enriched 10 related papers. Consider them for comparative context: